1978 related articles for article (PubMed ID: 19391033)
21. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer.
Ivkov R; DeNardo SJ; Daum W; Foreman AR; Goldstein RC; Nemkov VS; DeNardo GL
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7093s-7103s. PubMed ID: 16203808
[TBL] [Abstract][Full Text] [Related]
22. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.
Yan C; Chen D; Gu J; Qin J
J Pharm Pharmacol; 2006 Sep; 58(9):1177-81. PubMed ID: 16945175
[TBL] [Abstract][Full Text] [Related]
24. An in-vivo experimental study of temperature elevations in animal tissue during magnetic nanoparticle hyperthermia.
Salloum M; Ma R; Zhu L
Int J Hyperthermia; 2008 Nov; 24(7):589-601. PubMed ID: 18979310
[TBL] [Abstract][Full Text] [Related]
25. In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia.
Babincov M; Altanerov V; Altaner C; Bergemann C; Babinec P
IEEE Trans Nanobioscience; 2008 Mar; 7(1):15-9. PubMed ID: 18334449
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of heat shock protein 90 sensitizes melanoma cells to thermosensitive ferromagnetic particle-mediated hyperthermia with low Curie temperature.
Ito A; Saito H; Mitobe K; Minamiya Y; Takahashi N; Maruyama K; Motoyama S; Katayose Y; Ogawa J
Cancer Sci; 2009 Mar; 100(3):558-64. PubMed ID: 19154416
[TBL] [Abstract][Full Text] [Related]
27. Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies.
Zhu L; Ma J; Jia N; Zhao Y; Shen H
Colloids Surf B Biointerfaces; 2009 Jan; 68(1):1-6. PubMed ID: 19013060
[TBL] [Abstract][Full Text] [Related]
28. Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release.
Zhu A; Yuan L; Jin W; Dai S; Wang Q; Xue Z; Qin A
Acta Biomater; 2009 Jun; 5(5):1489-98. PubMed ID: 19286431
[TBL] [Abstract][Full Text] [Related]
29. In situ preparation of magnetic Fe3O4-chitosan nanoparticles for lipase immobilization by cross-linking and oxidation in aqueous solution.
Wu Y; Wang Y; Luo G; Dai Y
Bioresour Technol; 2009 Jul; 100(14):3459-64. PubMed ID: 19329306
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
[TBL] [Abstract][Full Text] [Related]
31. Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration.
Rodrigues HF; Mello FM; Branquinho LC; Zufelato N; Silveira-Lacerda EP; Bakuzis AF
Int J Hyperthermia; 2013 Dec; 29(8):752-67. PubMed ID: 24138472
[TBL] [Abstract][Full Text] [Related]
32. Nanohyperthermia of malignant tumors. II. In vivo tumor heating with manganese perovskite nanoparticles.
Bubnovskaya L; Belous A; Solopan A; Podoltsev A; Kondratenko I; Kovelskaya A; Sergienko T; Osinsky S
Exp Oncol; 2012 Dec; 34(4):336-9. PubMed ID: 23302992
[TBL] [Abstract][Full Text] [Related]
33. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia.
Fortin JP; Wilhelm C; Servais J; Ménager C; Bacri JC; Gazeau F
J Am Chem Soc; 2007 Mar; 129(9):2628-35. PubMed ID: 17266310
[TBL] [Abstract][Full Text] [Related]
34. Applications of magnetic nanoparticles in medicine: magnetic fluid hyperthermia.
Latorre M; Rinaldi C
P R Health Sci J; 2009 Sep; 28(3):227-38. PubMed ID: 19715115
[TBL] [Abstract][Full Text] [Related]
35. Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications.
Kettering M; Zorn H; Bremer-Streck S; Oehring H; Zeisberger M; Bergemann C; Hergt R; Halbhuber KJ; Kaiser WA; Hilger I
Phys Med Biol; 2009 Sep; 54(17):5109-21. PubMed ID: 19661569
[TBL] [Abstract][Full Text] [Related]
36. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
[TBL] [Abstract][Full Text] [Related]
37. Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles.
Wang L; Dong J; Ouyang W; Wang X; Tang J
Oncol Rep; 2012 Mar; 27(3):719-26. PubMed ID: 22134718
[TBL] [Abstract][Full Text] [Related]
38. Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
J Biosci Bioeng; 2005 Jul; 100(1):112-5. PubMed ID: 16233860
[TBL] [Abstract][Full Text] [Related]
39. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
40. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.
Johannsen M; Thiesen B; Gneveckow U; Taymoorian K; Waldöfner N; Scholz R; Deger S; Jung K; Loening SA; Jordan A
Prostate; 2006 Jan; 66(1):97-104. PubMed ID: 16114060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
